breakthroughs
Beyond Market Intelligence keeps breakthroughs in one place: 3 stories so far. The section currently leads with “Two fusion leaders map the path from breakthrough to the grid at Disrupt 2026”, “Explore how AI infrastructure is reshaping energy and grid systems”, and “Explore how AI unlocks new discoveries in life sciences funding”. Fusion energy has long felt like a future that never arrives. The Smart Systems Stage at TechCrunch Disrupt 2026 is where energy, infrastructure, and technology truly collide. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every breakthroughs story on Beyond Market Intelligence, newest first.
Two fusion leaders map the path from breakthrough to the grid at Disrupt 2026
Fusion energy has long felt like a future that never arrives. Two leaders determined to change that, CFS' Brandon Sorbom and Helion's David Kirtley, will bring real answers to Disrupt 2026. They'll map the path from laboratory breakthrough to grid-scale power, and the obstacles still in the way. If removing bottlenecks in energy sounds familiar, our piece on how Uber solved the same problem with data orchestration is worth your time. Secure your pass at regular price and bring a colleague for half off.
Explore how AI infrastructure is reshaping energy and grid systems
The Smart Systems Stage at TechCrunch Disrupt 2026 is where energy, infrastructure, and technology truly collide. Expect real talk on fusion breakthroughs and the mounting grid strain that AI is placing on the entire economy. It's a conversation about building smarter, not just faster. If you've been questioning how far AI should push our systems, our piece on questioning your AI clone offers a timely counterpoint. Explore the agenda and see where your next step fits.
Explore how AI unlocks new discoveries in life sciences funding
Miles Wang, an OpenAI researcher, is reportedly in talks to launch an AI-driven drug discovery startup with a $2 billion valuation. That's a striking signal of where the industry sees the next breakthrough. Investors are betting that AI can tackle the messy, high-stakes work of life sciences, not just automate spreadsheets. It's a bold move, and one that feels overdue. For anyone tracking how AI moves beyond data management into real-world impact, this is worth watching closely.